Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsIndustryCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Opthea (OPT) Debt to Equity (2004 - 2024)

Opthea (OPT) debt to equity from Jun 30, 2004 to Dec 31, 2024. The current Opthea (OPT) debt to equity is -132.04%. You can export chart.

Debt to Equity

Debt to Equity

Annual Debt to Equity change of Opthea (OPT)

YearDebt to EquityChange
2024-186.85%
+5982.96%
2023-3.07%
N/A
20220.00%
-100.00%
20210.08%
-80.02%
20200.42%
N/A
20190.00%
N/A
20180.00%
N/A
20170.00%
N/A
20160.00%
N/A
20150.00%
N/A
20140.00%
N/A
20130.00%
N/A
20120.00%
N/A
20110.00%
N/A
20100.00%
N/A
20090.00%
N/A
20080.00%
N/A
20070.00%
N/A
20060.00%
-100.00%
200513.36%
N/A

Comparison Opthea (OPT) debt to equity with competitors

Opthea (OPT) debt to equity is -132.04%.

TickerNameDebt to EquityUpside
DRUGBright Minds Biosciences Inc0.03%-100.02%
ARVNArvinas Inc0.13%-100.10%
GHRSGH Research PLC0.16%-100.12%
ATHEAlterity Therapeutics Ltd0.18%-100.14%
CGONCg Oncology Inc0.27%-100.21%
PHVSPharvaris NV0.31%-100.24%
OSRHBellevue Life Sciences Acquisition Corp0.37%-100.28%
GLPGGalapagos NV0.37%-100.28%
VTVTvTv Therapeutics Inc - Class A0.46%-100.35%
BDRXBiodexa Pharmaceuticals Plc0.53%-100.41%
LPTXLeap Therapeutics Inc0.68%-100.51%
CMNDClearmind Medicine Inc0.74%-100.56%
CBUSCibus Global Ltd. Class A0.75%-100.57%
ABVCABVC BioPharma Inc0.82%-100.62%
COEPCoeptis Therapeutics Holdings Inc. Common Stock0.87%-100.66%
PPCBPropanc Biopharma Inc1.05%-100.80%
ARGXArgen X SE1.14%-100.86%
OCSOculis Holding AG1.14%-100.87%
XRTXXORTX Therapeutics Inc1.17%-100.89%
IMMPImmutep Ltd1.22%-100.93%
CANFCan-Fite Biopharma Ltd1.27%-100.96%
RVPHReviva Pharmaceuticals Holdings Inc1.33%-101.00%
BNTXBioNTech SE1.62%-101.23%
NBPNovaBridge Biosciences.1.74%-101.32%
NRXSNeuraxis Inc1.75%-101.33%
IMABI-Mab1.77%-101.34%
IFRXInflaRx N.V.2.23%-101.69%
ONCOOnconetix Inc2.47%-101.87%
ENTOEntero Therapeutics, Inc. Common Stock2.51%-101.90%
GANXGain Therapeutics Inc2.67%-102.02%
NCNANuCana plc3.04%-102.30%
ADXNAddex Therapeutics Ltd3.11%-102.36%
SXTP60 Degrees Pharmaceuticals Inc3.29%-102.49%
IMTXImmatics N.V3.31%-102.51%
YMABY-Mabs Therapeutics Inc3.66%-102.77%
IRONDisc Medicine Inc4.27%-103.23%
LGVNLongeveron Inc - Class A4.67%-103.53%
MOLNMolecular Partners AG4.89%-103.70%
NCELNLS Pharmaceutics Ltd4.90%-103.71%
ADAGAdagene Inc5.23%-103.96%
PRTCPureTech Health plc American Depositary Shares5.56%-104.21%
ALXOAlx Oncology Holdings Inc5.62%-104.26%
REGNRegeneron Pharmaceuticals Inc6.32%-104.79%
ANROAlto Neuroscience Inc6.58%-104.99%
MDXGMimedx Group Inc7.24%-105.48%
GDTCCytoMed Therapeutics Ltd7.37%-105.58%
MRNAModerna Inc7.96%-106.03%
QLGNQualigen Therapeutics, Inc. Common Stock8.40%-106.36%
BEAMBeam Therapeutics Inc8.60%-106.52%
PBYIPuma Biotechnology Inc8.79%-106.65%
PYPDPolypid Ltd9.00%-106.82%
KURAKura Oncology Inc9.04%-106.84%
SLNOSoleno Therapeutics Inc10.06%-107.62%
VRAXVirax Biolabs Group Ltd - Class A10.13%-107.67%
SVASinovac Biotech Ltd11.15%-108.44%
RIGLRigel Pharmaceuticals11.25%-108.52%
MAZEMaze Therapeutics Inc11.36%-108.61%
ABEOAbeona Therapeutics Inc12.48%-109.45%
CLDICalidi Biotherapeutics Inc12.62%-109.56%
ACIUAC Immune SA13.65%-110.34%
MNMDMind Medicine (MindMed) Inc. Common Shares14.62%-111.07%
VERAVera Therapeutics Inc - Class A15.01%-111.37%
ALTAltimmune Inc15.25%-111.55%
NUVBNuvation Bio Inc - Class A16.62%-112.59%
SVRASavara Inc17.08%-112.94%
ACHVAchieve Life Sciences Inc17.21%-113.04%
DYNDyne Therapeutics Inc17.27%-113.08%
HRMYHarmony Biosciences Holdings Inc17.45%-113.21%
SPRBSpruce Biosciences Inc18.66%-114.13%
RCUSArcus Biosciences Inc19.08%-114.45%
INVAInnoviva Inc19.24%-114.57%
MDWDMediWound Ltd19.62%-114.86%
TARSTarsus Pharmaceuticals Inc20.80%-115.76%
XNCRXencor Inc21.05%-115.94%
TCRXTscan Therapeutics Inc22.51%-117.05%
APLSApellis Pharmaceuticals Inc22.59%-117.11%
CNTACentessa Pharmaceuticals plc22.66%-117.16%
BMRNBiomarin Pharmaceutical Inc23.02%-117.44%
TSHATaysha Gene Therapies Inc23.10%-117.50%
FBIOFortress Biotech Inc23.12%-117.51%
MESOMesoblast Ltd23.52%-117.81%
HYFTMindWalk Holdings Corp23.71%-117.96%
ONCBeiGene Ltd24.13%-118.28%
LXRXLexicon Pharmaceuticals Inc24.49%-118.55%
NKTRNektar Therapeutics24.89%-118.85%
ICCCImmucell Corp29.87%-122.62%
CRSPCRISPR Therapeutics AG32.27%-124.44%
ZLABZai Lab Ltd32.30%-124.46%
QUREuniQure N.V.33.44%-125.33%
ABOSAcumen Pharmaceuticals Inc35.49%-126.88%
ALDXAldeyra Therapeutics Inc36.29%-127.49%
PRQRProQR Therapeutics N.V36.40%-127.57%
OBIOOrchestra BioMed Holdings Inc36.41%-127.58%
COGTCogent Biosciences Inc36.72%-127.81%
ELABPMGC Holdings Inc37.62%-128.49%
ASBPAspire Biopharma Holdings Inc38.75%-129.35%
MLTXMoonLake Immunotherapeutics - Class A38.98%-129.52%
LEGNLegend Biotech Corp40.23%-130.47%
PHXMPHAXIAM Therapeutics SA ADR42.62%-132.28%
PHARPharming Group N.V.43.21%-132.72%
XFORX4 Pharmaceuticals Inc44.52%-133.72%
REPLReplimune Group Inc50.14%-137.97%
ADMAAdma Biologics Inc50.44%-138.20%
CLGNCollPlant Biotechnologies Ltd New54.22%-141.06%
BLRXBioline Rx Ltd54.40%-141.20%
SRPTSarepta Therapeutics Inc55.69%-142.18%
ARQTArcutis Biotherapeutics Inc57.70%-143.70%
MDGLMadrigal Pharmaceuticals Inc62.62%-147.43%
CAICaris Life Sciences Inc - Class A64.29%-148.69%
SRRKScholar Rock Holding Corp71.23%-153.95%
INSMInsmed Inc76.93%-158.26%
ATAIATAI Life Sciences N.V.83.95%-163.58%
VRNAVerona Pharma Plc87.12%-165.98%
IONSIonis Pharmaceuticals Inc88.01%-166.66%
RYTMRhythm Pharmaceuticals Inc88.25%-166.84%
RPRXRoyalty Pharma plc - Class A90.13%-168.26%
CDXSCodexis Inc93.64%-170.92%
ALECAlector Inc94.08%-171.25%
GMABGenmab94.17%-171.32%
TTRXTurn Therapeutics Inc97.04%-173.49%
GERNGeron Corp109.92%-183.25%
XOMAXOMA Royalty Corp110.48%-183.68%
TLXTelix Pharmaceuticals Ltd112.45%-185.17%
HCWBHCW Biologics Inc114.14%-186.44%
JAZZJazz Pharmaceuticals plc118.15%-189.48%
MRVIMaravai LifeSciences Holdings Inc - Class A119.30%-190.35%
TGTXTG Therapeutics Inc127.78%-196.78%
ARDXArdelyx Inc136.94%-203.71%
FOLDAmicus Therapeutics Inc143.18%-208.44%
QNTMFSD Pharma Inc - Class B - Class B (Sub Voting)146.17%-210.70%
AAPGAscentage Pharma Group International149.47%-213.20%
SLXNSilexion Therapeutics Corp149.83%-213.47%
SPRYARS Pharmaceuticals Inc157.44%-219.24%
NMRANeumora Therapeutics Inc159.82%-221.04%
MISTMilestone Pharmaceuticals Inc161.42%-222.26%
CLLSCellectis181.25%-237.27%
ASNDAscendis Pharma A/S183.75%-239.17%
FTREFortrea Holdings Inc200.32%-251.72%
AIMAIM ImmunoTech Inc.215.25%-263.02%
CELCCelcuity Inc257.58%-295.08%
HOWLWerewolf Therapeutics Inc262.95%-299.14%
VALNValneva SE273.15%-306.87%
ALLRAllarity Therapeutics Inc290.17%-319.76%
HUMAHumacyte Inc308.59%-333.71%
AXSMAxsome Therapeutics Inc344.13%-360.63%
ADAPAdaptimmune Therapeutics plc American Depositary Shares423.98%-421.10%
PGENPrecigen Inc462.16%-450.02%
OCGNOcugen Inc502.91%-480.88%
SNDXSyndax Pharmaceuticals Inc840.90%-736.86%
HALOHalozyme Therapeutics Inc976.45%-839.52%
EDITEditas Medicine Inc1240.40%-1039.42%
RVNCRevance Therapeutics Inc1477.84%-1219.24%
IOBTIO Biotech Inc1829.20%-1485.35%